June

2019

  • S
  • M
  • T
  • W
  • T
  • F
  • S
  •  
  •  
  •  
  •  
  •  
  •  
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  •  
  •  
  •  
  •  
  •  
  •  
  ThaiTECT Group ::

 

Who are we?
Thailand towards Excellence in Clinical Trials (ThaiTECT) was formed by several stakeholders  working on clinical trial processes in Thailand.  It is composed of personnel from the investigator groups, medical institutes, clinical research centers, ethics committees/institutional review boards, sponsors, and the Food and Drug Administration Thailand. We have voluntarily  worked together for a number of years towards excellent international standards in clinical trials in Thailand
 

 

Objectives of ThaiTECT

• To facilitate clinical trial processes by analyzing and recommending improvement areas to the appropriate official organizations or persons
• To enhance the development and potential of all clinical trial stakeholders in order to ensure even better Good Clinical Practice (GCP) adherence and compliance

• To help build and support new investigators, clinical research centers, ethics committees/institutional review boards
• To increase Thailand’s research and development (R & D) competitiveness in an increasingly more challenging environment to attract R&D investment in developing and emerging countries